A LEADING MEDICAL RESEARCH INSTITUTE SPECIALISING IN ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
Alzheimer’s Research Australia
With Professor Vicky Vass, Chief Executive Officer
ORGANISATIONS IN MEDICAL RESEARCH
Filmed in Perth, Western Australia | November 2024
Professor Vicky Vass serves as the Chief Executive Officer of Alzheimer’s Research Australia, which is based in Perth, Western Australia. Australian Health Journal met with Professor Vass to hear of the organisation’s mission to solve the mysteries surrounding Alzheimer’s disease, and focus on detection as the key to their efforts.
Founded in 1993, the organisation now comprises a large research team, a clinical trials division, and an administrative support team. Their aim is to make Alzheimer’s a distant memory through rigorous research.
Their philosophy revolves around operating as one cohesive team, which includes all these parts as well as the board, fostering effective collaboration. Leading this team is Professor Ralph Martins AO, as the Chief Inspector in their mission. He focuses on uncovering pathways for prevention, intervention, and the latest treatments for neurodegenerative diseases.
Among the key studies highlighted by Professor Vass is the blood biomarker study led by Professor Ralph Martins, which aims to develop a cost-effective method for detecting Alzheimer’s through a simple blood test. Currently, detection methods involve multiple scans and intense processes, but this initiative could transform the landscape by making detection more accessible and affordable.
Another study is run by Dr. Prashant Bharadwaj who heads the research on childhood dementia, focusing on providing hope to the youngest patients affected by these debilitating diseases. His work is dedicated to ensuring that children have a future filled with memories rather than loss, striving to find ways to detect and ultimately cure childhood dementia.
The board of Alzheimer’s Research Australia comprises a diverse group of individuals, including academics and those involved in commercial work and aged care. The common goal uniting them is to find a cure for Alzheimer’s disease. Funding for the organisation primarily comes from donations and rely heavily on this support, as they do not receive significant government funding, although they do get some grants for research.
Professor Vass describes Alzheimer’s Research Australia as an incredible place to work, boasting a community akin to a family. Every role within the organisation is respected, contributing to a common goal of making Alzheimer’s a distant memory for future generations.
-
CASE STUDY: Creating awareness, workforce education & dissemination strategy in national screening
At the recent Screening Conference 2025 in Sydney, hosted by Public Health Association, Dr Rachael Dodd, Senior Research Fellow at The Daffodil Centre, spoke about the information and educational resources created to increase awareness in the healthcare workforce and community on the upcoming Australia’s National Lung Cancer Screening Program commencing in July 2025.
-
The role of genomic screening in transforming public health
Dr Jane Tiller is a lawyer, genetic counsellor and public health researcher. She is Ethical, Legal & Social Adviser in Public Health Genomics at Monash University, and a National Health and Medical Research Council Investigator Grant holder. Jane is passionate about the use of genomics to prevent disease, and in delivering equitable access to preventive genetic information at the population level. She is co-lead of DNA Screen, a world-first study piloting the offer of preventive DNA screening to the Australian adult population. DNA Screen has tested over 10,000 young people for genetic high risk of medically actionable conditions such as cancer and heart disease, finding about 2% of participants had genetic high risk. Jane is leading efforts to secure Commonwealth Government funding to expand the DNA Screen program, with the eventual goal of the development of a public health population screening program for disease prevention based on high genetic risk.
-
Improvements in dental literacy and greater clinical insights through digital technology
Dr. Kenneth Soh is a General Dentist based in Kellyville, New South Wales, a suburb located in northwestern Sydney. Originally from Melbourne, he studied Bachelor of Dental Science (BDSc) at Melbourne University and graduated in 2003. After working for a year in the Mornington Peninsula, Dr. Soh moved to New South Wales, initially thinking it would be temporary; however, he has been there for 19 years. While he has considered specialising, he finds joy in all aspects of dentistry.
